Harmony biosciences
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases and unmet medical needs.
Harmony biosciences Overview
Harmony biosciences Funding Rounds
Round | Date | Amount Raised | Valuation | Investors | Sources |
---|---|---|---|---|---|
IPO | 8/11/2020 | ||||
Series C | 8/6/2019 | ||||
Early Stage VC | 1/18/2018 |
Harmony biosciences Investors
Investor | Investment Rounds | Lead Partner | Initial Investment | Other Notable Investments |
---|---|---|---|---|
Novo Holdings | Early Stage VC | Early Stage VC (2018-01-18) | ||
Valor Equity Partners | Early Stage VC | Early Stage VC (2018-01-18) |
Harmony biosciences 409a Valuations
Date | Price per share | Est. Valuation | Filling |
---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Harmony biosciences Filings
Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Latest Harmony biosciences News
Get Ready for Harmony Biosciences’ Q3 2024 Financial Results
MSNOctober 20, 2024
Get Ready for Harmony Biosciences’ Q3 2024 Financial Results
MyChesCoOctober 19, 2024
Harmony Biosciences Set to Engage at Key Investor Conferences
MSNOctober 16, 2024
Wall Street Analysts Favor Harmony Biosciences Holdings, Inc. (HRMY) for Growth
Insider MonkeyOctober 14, 2024
Harmony Biosciences Earns Membership In 95-Plus Composite Rating Club
Investor's Business DailyOctober 14, 2024
Livforsakringsbolaget Skandia Omsesidigt Has $1.80 Million Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
MarketBeatOctober 13, 2024
Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) The Top Stock With Improving Technical Ratings According To Piper Sandler?
Yahoo FinanceOctober 11, 2024
Harmony Biosciences resumed with an Outperform at Raymond James
TipRanksOctober 10, 2024